HilleVax Inc

NASDAQ:HLVX   4:00:00 PM EDT
19.03
-2.34 (-10.95%)
4:02:06 PM EDT: $19.03 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

HilleVax Inc Stock, NASDAQ:HLVX

75 State Street, Suite 100, Boston, Massachusetts 02109
United States of America
Phone: +1.617.213.5054
Number of Employees:

Description

HilleVax, Inc. operates as a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Its initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was founded by Dr. Maurice Hilleman and Dr. Tadataka Yamada on 3rd March, 2020 and is headquartered in Boston, MA.